
3T is an immunotherapy company developing next-generation, transformative therapies for the treatment of solid tumors and other immune-mediated diseases in broad patient populations.
11 - 50 employees
Founded 2017
💰 $40M Series A on 2022-08
June 10
11 - 50
Remote sales position for NGS solutions, covering Central US regions with a focus on laboratories.
⛰️ Colorado – Remote
🌽 Illinois – Remote
+11 more states
💰 $40M Series A on 2022-08
⏰ Full Time
🟠 Senior
🔴 Lead
🧑💼 Account Executive